Connection
Matthew Greenhawt to Self Administration
This is a "connection" page, showing publications Matthew Greenhawt has written about Self Administration.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.088 |
|
|
|
-
Shaker M, Greenhawt M. Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis. JAMA Netw Open. 2018 11 02; 1(7):e184728.
Score: 0.610
-
Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
Score: 0.170
-
Sun D, Cafone J, Shaker M, Greenhawt M. The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy. Ann Allergy Asthma Immunol. 2019 12; 123(6):582-589.
Score: 0.162
-
Greenhawt M, Hourihane JO. Looking into the seeds of time: Are home-based OIT programs the shape of things to come for selected patients? Ann Allergy Asthma Immunol. 2018 05; 120(5):453-454.
Score: 0.147